Ranitidine

Ranitidine is a member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease. Classified as a histamine H2-receptor antagonist, and belongs to the same drug class as cimetidine and famotidine. Ranitidine is among H2 blockers the most potent inhibitor of acetylcholinesterase but roughly three to four orders of magnitude less potent than paraoxon (an irreversible organophosphate esterase inhibitor) or pyridostigmine

General

Type : Multitarget, Not A\/B H target, Sulfur Compound

Chemical_Nomenclature : (E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine

Canonical SMILES : CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C

InChI : InChI=1S\/C13H22N4O3S\/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3\/h4-5,9,14-15H,6-8,10H2,1-3H3\/b13-9+

InChIKey : VMXUWOKSQNHOCA-UKTHLTGXSA-N

Other name(s) : Zantac  ||  Ranitidine Base  ||  ranitidine hydrochloride  ||  Raticina  ||  CHEBI:8776  ||  CHEMBL512  ||  CHEBI:92246


MW : 314.41

Formula : C13H22N4O3S

CAS_number : 66357-35-5

PubChem : 3001055

UniChem : VMXUWOKSQNHOCA-UKTHLTGXSA-N

Target

References (18)

Title : Design and Synthesis of Ranitidine Analogs as Multi-Target Directed Ligands for the Treatment of Alzheimer's Disease - Gao_2021_Int.J.Mol.Sci_22_
Author(s) : Gao J , Suo C , Tseng JH , Moss MA , Terry AV, Jr. , Chapman J
Ref : Int J Mol Sci , 22 : , 2021
Abstract :
PubMedSearch : Gao_2021_Int.J.Mol.Sci_22_
PubMedID: 33803769

Title : Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine - Petroianu_2006_Basic.Clin.Pharmacol.Toxicol_99_312
Author(s) : Petroianu GA , Hasan MY , Nurulain SM , Shafiullah M , Sheen R , Nagelkerke N
Ref : Basic Clin Pharmacol Toxicol , 99 :312 , 2006
Abstract :
PubMedSearch : Petroianu_2006_Basic.Clin.Pharmacol.Toxicol_99_312
PubMedID: 17040217

Title : Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro - Bartling_2005_J.Appl.Toxicol_25_568
Author(s) : Bartling A , Thiermann H , Szinicz L , Worek F
Ref : J Appl Toxicol , 25 :568 , 2005
Abstract :
PubMedSearch : Bartling_2005_J.Appl.Toxicol_25_568
PubMedID: 16167316

Title : Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine - Petroianu_2005_J.Appl.Toxicol_25_60
Author(s) : Petroianu GA , Arafat K , Schmitt A , Hasan MY
Ref : J Appl Toxicol , 25 :60 , 2005
Abstract :
PubMedSearch : Petroianu_2005_J.Appl.Toxicol_25_60
PubMedID: 15669026

Title : Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats - Petroianu_2005_J.Appl.Toxicol_25_68
Author(s) : Petroianu GA , Hasan MY , Nurulain SM , Arafat K , Sha Ullah M , Naseer O
Ref : J Appl Toxicol , 25 :68 , 2005
Abstract :
PubMedSearch : Petroianu_2005_J.Appl.Toxicol_25_68
PubMedID: 15669039

Title : Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine - Sowell_1992_J.Med.Chem_35_1102
Author(s) : Sowell JW, Sr. , Tang Y , Valli MJ , Chapman JM, Jr. , Usher LA , Vaughan CM , Kosh JW
Ref : Journal of Medicinal Chemistry , 35 :1102 , 1992
Abstract :
PubMedSearch : Sowell_1992_J.Med.Chem_35_1102
PubMedID: 1552502

Title : Synthesis and cholinergic properties of N-aryl-2-[[[5- [(dimethylamino)methyl]-2-furanyl]methyl]thio]ethylamino analogs of ranitidine - Valli_1992_J.Med.Chem_35_3141
Author(s) : Valli MJ , Tang Y , Kosh JW , Chapman JM, Jr. , Sowell JW, Sr.
Ref : Journal of Medicinal Chemistry , 35 :3141 , 1992
Abstract :
PubMedSearch : Valli_1992_J.Med.Chem_35_3141
PubMedID: 1507203

Title : The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis - Londong_1992_Aliment.Pharmacol.Ther_6_609
Author(s) : Londong W , Phillips J , Johnson NJ , Wood JR
Ref : Aliment Pharmacol Ther , 6 :609 , 1992
Abstract :
PubMedSearch : Londong_1992_Aliment.Pharmacol.Ther_6_609
PubMedID: 1420752

Title : Poster: Anticholinesterase and neuromuscular blocking activity of ranitidine and nizatidine on the Toad Rectus Abdominis Muscle\; Comparison with Physostigmine -
Author(s) : Kounenis G
Ref : In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology , (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC :267 , 1991
PubMedID:

Title : Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat - Riedel_1988_Digestion_40_25
Author(s) : Riedel R , Bohnenkamp W , Eltze M , Heintze K , Prinz W , Kromer W
Ref : Digestion , 40 :25 , 1988
Abstract :
PubMedSearch : Riedel_1988_Digestion_40_25
PubMedID: 3234616

Title : The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine - Scarpignato_1986_Digestion_33_7
Author(s) : Scarpignato C , Tangwa M , Tramacere R , Del Soldato P
Ref : Digestion , 33 :7 , 1986
Abstract :
PubMedSearch : Scarpignato_1986_Digestion_33_7
PubMedID: 2866139

Title : Poster: Interactions of pirenzepine and ranitidine in man - pharmacodynamic secretory studies -
Author(s) : Londong W , Bozler G , Eberl H , Gugler R , Londong V , Poch G
Ref : Trends in Pharmacological Sciences , Suppl :89 , 1986
PubMedID:

Title : The effect of ranitidine on exocrine pancreatic secretion in the rat - Chariot_1985_Arch.Int.Pharmacodyn.Ther_274_166
Author(s) : Chariot J , Roze C , Scarpignato C
Ref : Archives Internationales de Pharmacodynamie et de Therapie , 274 :166 , 1985
Abstract :
PubMedSearch : Chariot_1985_Arch.Int.Pharmacodyn.Ther_274_166
PubMedID: 4015260

Title : Poster 64 Ranitidine is a rapidly reversible inhibitor of acetylcholineterase -
Author(s) : Mantovani P , Galli A , Pepeu G
Ref : In: Cholinesterases, fundamental and applied aspects : proceedings of the Second International Meeting on Cholinesterases , (Brzin M, Barnard EA, Sket D, Eds) De Gruyter , 1984
PubMedID:

Title : Effect of ranitidine on ileal myenteric plexus preparation and on acetyl- and butyrylcholinesterase - Galli_1984_Biochem.Pharmacol_33_1845
Author(s) : Galli A , Mantovani P , Pepeu G
Ref : Biochemical Pharmacology , 33 :1845 , 1984
Abstract :
PubMedSearch : Galli_1984_Biochem.Pharmacol_33_1845
PubMedID: 6329222

Title : Inhibition of cholinesterases by ranitidine [letter] -
Author(s) : Hansen WE , Bertl S
Ref : Lancet , 1 :235 , 1983
PubMedID: 6130261

Title : Inhibition of basal acid, chloride, and pepsin secretion in duodenal ulcer by graded doses of ranitidine and atropine with studies of pharmacokinetics of ranitidine -
Author(s) : Hirschowitz BI , Danilewitz M , Molina E
Ref : Gastroenterology , 82 :1314 , 1982
PubMedID: 6279466

Title : Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine - Londong_1981_Gut_22_542
Author(s) : Londong W , Londong V , Ruthe C , Weizert P
Ref : Gut , 22 :542 , 1981
Abstract :
PubMedSearch : Londong_1981_Gut_22_542
PubMedID: 6114900